Last week, our team at BioMarket Connect (BMC) had the privilege of participating in the CACLP Expo 2025 in Hangzhou, Asia’s largest and most influential platform for the in vitro diagnostics (IVD) industry. Organized by #caclp, this flagship event spanned 130,000 sqm and attracted 1,346+ exhibitors and 81,261+ professionals worldwide, solidifying its role as a nexus for global IVD innovation, academic exchange, and market collaboration.

We’re honored to have supported two pioneering international partners—Athens Technology (USA) and Yashraj Biotechnology (India)—in launching their China market journey. From end-to-end booth design and logistics to crafting culturally resonant marketing materials, BMC ensured their brands stood out in this competitive arena.

A heartfelt thanks to our team and partners for their trust. The verdict? “Professional, proactive, and precise!”

Why CACLP Matters：A Quick Background

Debuted in 1991, China International In Vitro Diagnostic Expo by CACLP, is well established as one of the largest exhibitions in the in vitro diagnostic industry worldwide. China IVD Supply Chain Expo, successfully launched since 2021, further expand the product sectors from upstream to downstream. The great number of high-level academic and educational programs taking place concurrently onsite and year-round promotional solutions make CACLP one of the most important platforms for global IVD players.

As the premier hub for IVD advancements, CACLP 2025 showcased cutting-edge technologies across biochemical analysis, molecular diagnostics, and AI-driven lab solutions, while fostering partnerships between global players and China’s rapidly growing healthcare sector. With 40+ countries represented and dedicated forums on cross-border expansion, the event underscored China’s critical role in shaping the future of diagnostics.